Cogent Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	241.21	312.01	98.17	53.23	139.89	219.68
Short-Term Investments	625.17	588.75	188.91	212.48	119.39	-
Cash & Short-Term Investments	866.38	900.77	287.08	265.71	259.28	219.68
Cash Growth	252.67%	213.77%	8.04%	2.48%	18.02%	-9.29%
Other Current Assets	11.43	9.59	9.4	5.06	5.69	2.95
Total Current Assets	877.8	910.36	296.47	270.77	264.97	222.63
Net Property, Plant & Equipment	22.85	23.54	26.56	30.34	31.1	4.48
Long-Term Investments	-	-	-	7.46	-	-
Other Long-Term Assets	2.36	3.72	4.86	4.86	4.75	4.98
Total Assets	903.01	937.61	327.9	313.44	300.81	232.09
Accounts Payable	13.74	9.5	12.01	10.66	5.84	3.48
Accrued Expenses	42.85	52.9	42.13	26.13	17.88	8.21
Current Portion of Leases	1.38	1.55	1.57	1.39	1.42	2.32
Other Current Liabilities	-	-	-	-	1.7	3.06
Total Current Liabilities	57.98	63.95	55.71	38.17	26.85	17.08
Long-Term Debt	223.17	222.9	-	-	-	-
Long-Term Leases	14.1	14.36	15.9	17.47	18.23	0.83
Other Long-Term Liabilities	0.06	0.03	-	-	-	-
Total Long-Term Liabilities	237.33	237.28	15.9	17.47	18.23	0.83
Total Liabilities	295.31	301.24	71.61	55.64	45.08	17.91
Preferred Stock	64.75	89.39	110.6	60.04	65.83	85.4
Common Stock	0.17	0.16	0.11	0.09	0.07	0.04
Additional Paid-in Capital	1,829	1,735	1,005	801.06	601.15	399.71
Accumulated Other Comprehensive Income	-0.42	0.36	0.45	0.25	-0.1	-
Retained Earnings	-1,286	-1,188	-859.48	-603.62	-411.21	-270.97
Shareholders' Equity	607.69	636.37	256.29	257.8	255.74	214.18
Total Liabilities & Equity	903.01	937.61	327.9	313.44	300.81	232.09
Total Debt	238.65	238.8	17.47	18.85	19.65	3.16
Net Cash (Debt)	627.73	661.97	269.61	246.86	239.63	216.53
Net Cash Growth	-5.17%	145.53%	9.22%	3.02%	10.67%	-8.63%
Net Cash Per Share	4.45	5.14	2.60	3.10	4.08	5.59
Book Value	607.69	636.37	256.29	257.8	255.74	214.18
Book Value Per Share	4.31	4.94	2.47	3.24	4.35	5.53
Tangible Book Value	607.69	636.37	256.29	257.8	255.74	214.18
Tangible Book Value Per Share	4.31	4.94	2.47	3.24	4.35	5.53

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q